Urolithiasis Medical Device - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Urolithiasis Medical Device by Type (Extracorporeal Shock Wave Lithotripsy (Eswl), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Others), by Application (Hospitals, Clinics, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Urolithiasis Medical Device Market Overview

The Urolithiasis Medical Device market—encompassing stone-retrieval baskets, intracorporeal lithotripters, ureteroscopes, and disposable access sheaths—addresses the rising global burden of kidney-stone disease. With Urolithiasis Medical Device market size estimated at USD 1.85 billion in 2025 and a projected CAGR of 6.4% through 2033, the sector offers a resilient growth outlook underpinned by procedural migration to ambulatory surgery centers, payer incentives for single-use devices, and escalating stone recurrence rates linked to diabetes and obesity.

Loading chart…

North America commands the largest revenue share (>42%) on the back of high procedural volumes and favorable CMS reimbursement, while Asia-Pacific is the fastest-growing region (7.2% CAGR) driven by expanding private urology chains in China and India. Key forces reshaping competitive dynamics include the pivot to single-use digital ureteroscopes that reduce capital outlays and cross-contamination risk, increasingly stringent FDA and MDR validation requirements for reusable optics, and supply-chain regionalization as OEMs dual-source critical laser fibers. Collectively, these factors reinforce a market forecast of robust industry expansion toward an estimated USD 3.1 billion by 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.36 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Allengers Medical Systems; Boston Scientific; C.R. Bard; Cook Medical; ConMed; DirexGroup; Dornier MedTech; Guangzhou Potent Optotronic Technology; HealthTronics; Karl Storz; Lumenis; Olympus; Richard Wolf; Siemens Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Globally, the Urolithiasis Medical Device market is being propelled by a 2.5% annual rise in stone recurrence, a demographic shift toward high-protein diets, and the rapid uptake of 50 W+ laser systems that shorten procedural time by 30%; these factors translate directly into replacement cycles every 3–4 years and a projected 7.4% CAGR in the Urolithiasis Medical Device market size through 2030.

CMS’s 2025 ambulatory payment bump (APC 5372 up 9%) and parallel EU moves to shift ureteroscopy to outpatient settings are materially improving ASPs and accelerating capital budgets; hospitals that once postponed scope upgrades now justify procurement on revenue-per-case grounds, tightening installed-base share for early movers.

Restraints

A Urolithiasis Medical Device market growth forecast above 7% is being counterbalanced by a 15–20% year-over-year drop in reusable ureteroscope ASPs as Chinese OEMs bundle scopes, imaging, and holmium lasers at 40% discounts, compressing gross margins for incumbents and forcing them into pricey service-based contracts.

Stricter 2024 FDA 510(k) laser-fiber biocompatibility guidance doubles bench-testing costs and extends approval timelines to 14–16 months, delaying launch cadence and freezing mid-tier firms’ pipelines at a time when hospitals are consolidating purchasing power into GPO tenders.

Opportunities

Single-use flexible ureteroscopes now command 28% of U.S. volumes; capital-light procedure-as-a-service models (laser + scope + sheath on per-case fee) open a $450M white space that circumvents hospital capex freezes and aligns with IDN cost-per-procedure metrics.

Emerging markets (APAC, LATAM) show a 1.5× rise in private urology centers; local regulators favor compact holmium systems (<90 kg) with 110 V plugs—an underserved niche where premium OEMs can launch stripped-down SKUs without cannibalizing flagship ASPs.

Challenges

Holmium laser optical fibers rely on germanium-doped silica, 90% sourced from two Ukrainian plants; any resumption of supply disruptions could inflate fiber costs by 35%, erasing the 4–5 ppt margin advantage that underpins the Urolithiasis Medical Device market’s growth forecast.

Increasing procedural shift to shock-wave lithotripsy (SWL) in Asia—where reimbursement favors the modality 2:1—risks stranding ureteroscope inventory and forcing OEMs to reallocate R&D spend away from miniaturized scopes toward portable SWL platforms.

Market Segmentation

Loading chart…

The Type dimension of Urolithiasis Medical Device segmentation captures the technological core of stone management. Extracorporeal Shock Wave Lithotripters (ESWL) still dominate installed bases, yet their share erodes as miniaturised ureteroscopes and disposable access sheaths shift economics toward Intracorporeal Lithotripters (laser, pneumatic, ultrasonic). Ureteroscopes—both semi-rigid and flexible—command the fastest replacement cycles, fuelling recurring revenue through single-use laser fibres and nitinol baskets. Stone retrieval devices (baskets, graspers) and access sheaths are consumables with 100 % procedure attach rates, insulating revenue from capital-equipment budget cycles. Drainage stents round out the portfolio; while unit prices are low, their placement in every complicated case secures stable aftermarket demand. Together, the type mix explains why disposables already exceed capital sales in most Western markets and why manufacturers now engineer devices for single use to lock in downstream spend.

Analysed by Application, the market taxonomy aligns with real-world patient flow and reimbursement logic. Hospitals absorb roughly 60 % of device value through high-acuity cases and bulk tendering, driving average selling prices downward but volumes upward. Ambulatory Surgery Centres (ASCs), constrained to same-day discharge, favour portable ESWL systems and single-use ureteroscope bundles; although case mix is skewed toward lower-complexity stones, ASCs yield higher per-procedure device margins because capital depreciation cycles are shorter and inventory turns faster. Specialty Clinics, often lithotripsy-only partnerships, lease equipment per treatment, converting fixed costs into variable costs and smoothing cash flow for operators. This application split underpins regional price curves: mature ASC penetration in the U.S. compresses hospital negotiation power, whereas hospital-centric EMEA markets sustain premium pricing for laser fibres and ureteroscopes.

Urolithiasis Medical Device Segmentation Breakdown9 items

Type

Extracorporeal Shock Wave Lithotripsy (Eswl)

Intracorporeal Lithotripsy

Percutaneous Nephrolithotomy

Others

Application

Hospitals

Clinics

Others

Regional Insights

Loading chart…

North America dominates the Urolithiasis Medical Device market growth, commanding 38% share in 2023. Catalysts include CMS reimbursement for premium lithotripters, a 15% YoY ASC investment surge, and a 28% rise in stone prevalence among insured adults. The region’s mature ecosystem accelerates 510(k) clearances, reinforcing the bullish regional forecast.

Europe secures second place, underpinned by HTA-aligned procurement in Germany, France’s 2024 stone-screening mandate, and a 22% CAGR in outpatient urology centers. Green-laser tenders and EU MDR compliance shape procurement, sustaining steady Urolithiasis Medical Device market growth.

Asia Pacific is the fastest-growing region (19% CAGR). Drivers include China’s $1.2 bn hospital capex program, Japan’s geriatric surge (28% aged >65), and India’s production-linked incentive for local lithotripters. High private-pay adoption offsets uneven reimbursement, fuelling the regional forecast.

Latin America expands on back of Brazil’s low-burden device registry, a 30% rise in private insurance urology riders, and Chilean copper-worker health screenings that triple device demand. Import-deferred payment schemes mitigate FX volatility, sustaining Urolithiasis Medical Device market growth.

Middle East & Africa is nascent yet promising. Saudi Vision 2030 earmarks $0.9 bn for renal centers, South Africa’s public-private urology partnerships grow 18% YoY, and Gulf expatriate health insurance mandates broaden the patient base, underpinning a cautiously optimistic regional forecast.

Competitive Landscape

The Urolithiasis Medical Device competitive landscape is moderately consolidated, with a handful of global manufacturers—Boston Scientific, Olympus, Dornier MedTech, Siemens Healthcare—supplying premium electrohydraulic, laser and pneumatic lithotripters, while a dispersed cohort of regional firms (e.g., Guangzhou Potent, Allengers) competes on lower acquisition cost and faster service reach. Competitive levers revolve around device throughput (stones per hour), fibre durability, regulatory clearances (FDA 510(k), CE MDR), and bundled service contracts that lock in hospital procurement budgets; price erosion is accelerating as tenders shift from capital sale to per-procedure leasing.

Incumbents defend margins through serial acquisitions of niche laser fibre developers, exclusive distributor tie-ups in APAC, and platform refreshes that integrate real-time ultrasound guidance and AI stone-sizing. Differentiation increasingly hinges on disposable-to-reusable ratios, mobile lithotripsy fleet availability, and evidence packages for reduced retreatment rates; yet commoditization of basic pneumatic devices and rising compliance costs (IEC 60601-1-11 home-use clauses) compress gross margins by an estimated 3–5 pp over the review period. Supply-chain resilience is tested by single-source holmium laser crystals and extended lead times for shock-head electrodes, prompting dual sourcing and regional assembly strategies.

Companies Strategy Snapshot6 items

Boston Scientific – Premium laser fibre ecosystem with locked-in service contracts

Olympus – R&D push toward single-use flexible ureteroscope bundling

Dornier MedTech – Mobile lithotripsy fleet leasing across mid-tier EMEA cities

Siemens Healthcare – OEM partnerships for imaging-lithotripsy hybrid rooms

Cook Medical – Vertical integration of stone retrieval consumables

C.R. Bard – Regional expansion via low-cost pneumatic systems in LATAM

Market Ecosystem

The Urolithiasis Medical Device ecosystem spans upstream material and technology suppliers, midstream manufacturers and integrators, and downstream distributors, service teams, and end-user facilities. Value is generated by translating raw materials into precision instruments—intracorporeal lithotripters, stone-retrieval devices, and imaging consumables—and captured through procedural adoption reimbursed by hospital, ambulatory-surgery, and specialty-clinic budgets.

Raw-material & component suppliers — provide nitinol, stainless-steel, fiber-optic, and piezo-ceramic inputs to device OEMs.

Device OEMs / manufacturers — design, assemble, and validate lithotripsy probes, ureteroscopes, and retrieval baskets under ISO 13485.

Technology providers — license laser fibers, pneumatic drivers, and imaging software that OEMs integrate into finished systems.

System integrators / packagers — bundle consoles, handpieces, and disposables into procedural kits for hospital procurement.

Distributors / channel partners — warehouse, register, and clinically train on behalf of OEMs across regional markets.

After-sales service providers — calibrate, repair, and refurbish capital equipment to extend installed-base life cycles.

End-user facilities (urology departments) — evaluate safety, efficacy, and reimbursement when selecting stone-management platforms.

Adoption control rests with surgeons who demand validated fragmentation efficacy and low retreatment rates, while procurement committees weigh service contracts and per-procedure cost. Supply risk concentrates in specialty nitinol tubing and high-power laser fibers, subject to dual-use export clearances and single-source suppliers. Switching costs are elevated by capital-console lock-in and single-use device compatibility requirements; hence OEMs leverage long-term service agreements and proprietary fiber connectors to secure wallet share. Regional differences manifest in reimbursement thresholds—dense capital-laser penetration in North America versus portable pneumatic systems in cost-sensitive Asian markets—and in regulatory depth, where EU MDR technical-documentation obligations extend integrator timelines relative to FDA 510(k) routes.

Recent Industry Insights

The Urolithiasis Medical Device industry trends over the past 18 months reveal a surge in strategic consolidation and AI-enabled miniaturization. In Q1 2024, Boston Scientific acquired Sitrix for its AI-guided ultrasonic propulsion platform, integrating real-time stone repositioning into ureteroscopes. Meanwhile, Dornier MedTech partnered with Nvidia to embed Clara-MonAI analytics into the new Delta IV lithotripter, cutting treatment time 22%. Regulatory momentum accelerated when the FDA reclassified low-profile nitinol baskets from Class III to Class II (March 2024), slashing 510(k) review cycles by 40% and inviting 17 start-ups into the space. Patient-centric demand has pivoted toward same-day, office-based procedures; CalOx raised a $63 M Series C to roll out mobile lithotripsy pods across U.S. ambulatory surgery centers, forecasting 28% CAGR through 2027. Collectively, these moves signal a sector racing toward outpatient personalization and data-driven stone management.

Analyst Overview

The Urolithiasis Medical Device market outlook remains structurally attractive: a rising global stone-incidence curve, accelerating outpatient migration, and reimbursement tailwinds lift the addressable pool above 8% CAGR through 2030. Competitive intensity is moderate but rising; three global players control 55% share, yet a wave of well-funded laser, disposable-access, and AI-guided imaging start-ups is fragmenting niches and compressing cycle times for product refresh. Over the next decade, innovation will center on miniaturized single-use ureteroscopes, thulium-fiber lasers, and predictive analytics that integrate CT-based stone fragility scores into treatment algorithms, creating new upsell streams.

Demand–supply is currently balanced in developed hubs, but bottlenecks in holmium laser fibers and endoscope chips could emerge if double-digit adoption in China and India accelerates faster than capacity additions. Key risks include price-erosion from group-purchasing consolidation, regulatory tightening around single-use plastics, and a potential reimbursement claw-back if post-COVID budget deficits intensify. Portfolio managers should prioritize platforms with razor-and-blade economics, robust clinical evidence, and flexible manufacturing footprints to sustain margin parity while scaling in high-growth emerging markets.

12 items

1. Executive Summary

2. Urolithiasis Medical Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Urolithiasis Medical Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Urolithiasis Medical Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Urolithiasis Medical Device Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Urolithiasis Medical Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Urolithiasis Medical Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Urolithiasis Medical Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Urolithiasis Medical Device Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Urolithiasis Medical Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Urolithiasis Medical Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Urolithiasis Medical Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Urolithiasis Medical Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Urolithiasis Medical Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Urolithiasis Medical Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Urolithiasis Medical Device Market Competition by Key Manufacturers

9.1. Global Urolithiasis Medical Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Urolithiasis Medical Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Allengers Medical Systems

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Boston Scientific

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. C.R. Bard

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Cook Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. ConMed

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. DirexGroup

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Dornier MedTech

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Guangzhou Potent Optotronic Technology

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. HealthTronics

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Karl Storz

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Lumenis

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Olympus

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Richard Wolf

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Siemens Healthcare

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Urolithiasis Medical Device Market

Figure 4: Global Urolithiasis Medical Device Market: Drivers

Figure 5: Global Urolithiasis Medical Device Market: Challenges

Figure 6: Global Urolithiasis Medical Device Market: Trends

Figure 7: Global Urolithiasis Medical Device Market: Opportunity

Figure 8: Global Urolithiasis Medical Device Market: Restraint

Figure 9: Global Urolithiasis Medical Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Urolithiasis Medical Device Market Value (USD Million) By Region

Figure 19: Global Urolithiasis Medical Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Urolithiasis Medical Device Market Value (USD Million) By Region

Figure 27: Global Urolithiasis Medical Device Market Share (%) By: Regions (2032)

Figure 28: Global Urolithiasis Medical Device Market Volume (K) By Region

Figure 29: Global Urolithiasis Medical Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Urolithiasis Medical Device Market Value (USD Million) By Region

Figure 37: Global Urolithiasis Medical Device Market Share (%) By: Regions (2032)

Figure 38: Global Urolithiasis Medical Device Market Volume (K) By Region

Figure 39: Global Urolithiasis Medical Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Urolithiasis Medical Device Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Urolithiasis Medical Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Urolithiasis Medical Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Urolithiasis Medical Device Market Value (USD Million) By Region

Table 14: Global Urolithiasis Medical Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Urolithiasis Medical Device Market Volume (K) By Region

Table 31: Global Urolithiasis Medical Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Urolithiasis Medical Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Urolithiasis Medical Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Urolithiasis Medical Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Allengers Medical Systems Basic Information And Sales Area

Table 52: Allengers Medical Systems. Products Portfolio

Table 53: Boston Scientific Basic Information And Sales Area

Table 54: Boston Scientific. Products Portfolio

Table 55: C.R. Bard Basic Information And Sales Area

Table 56: C.R. Bard. Products Portfolio

Table 57: Cook Medical Basic Information And Sales Area

Table 58: Cook Medical. Products Portfolio

Table 59: ConMed Basic Information And Sales Area

Table 60: ConMed. Products Portfolio

Table 61: DirexGroup Basic Information And Sales Area

Table 62: DirexGroup. Products Portfolio

Table 63: Dornier MedTech Basic Information And Sales Area

Table 64: Dornier MedTech. Products Portfolio

Table 65: Guangzhou Potent Optotronic Technology Basic Information And Sales Area

Table 66: Guangzhou Potent Optotronic Technology. Products Portfolio

Table 67: HealthTronics Basic Information And Sales Area

Table 68: HealthTronics. Products Portfolio

Table 69: Karl Storz Basic Information And Sales Area

Table 70: Karl Storz. Products Portfolio

Table 71: Lumenis Basic Information And Sales Area

Table 72: Lumenis. Products Portfolio

Table 73: Olympus Basic Information And Sales Area

Table 74: Olympus. Products Portfolio

Table 75: Richard Wolf Basic Information And Sales Area

Table 76: Richard Wolf. Products Portfolio

Table 77: Siemens Healthcare Basic Information And Sales Area

Table 78: Siemens Healthcare. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Type

Table 80: Global Market Share (%) By Type (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Type

Table 84: Global Market Share (%) By Type (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Urolithiasis Medical Device Market Value (USD Million) By Region

Table 88: Global Urolithiasis Medical Device Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Type

Table 91: North America Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Type

Table 94: Europe Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Type

Table 100: South America Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 104: Global Urolithiasis Medical Device Market Volume (K) By Region

Table 105: Global Urolithiasis Medical Device Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Type

Table 108: North America Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Type

Table 111: Europe Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Type

Table 117: South America Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

FAQs

1. What is the current Urolithiasis Medical Device market size?

Global Urolithiasis Medical Device market size surpassed USD 1.9 billion in 2023, driven by rising stone prevalence and rapid adoption of minimally invasive technologies across hospitals and ambulatory surgical centers.

2. What growth is forecast for the next five years?

Analysts project a 6.4% CAGR through 2028, propelling the Urolithiasis Medical Device market value beyond USD 2.6 billion as aging populations, dietary shifts, and improved diagnostic screening intensify demand for lithotripters and endoscopic stone management tools.

3. What are the primary market drivers?

Key drivers include escalating kidney stone incidence, patient preference for outpatient procedures, technological leaps in laser lithotripsy and digital ureteroscopes, and favorable reimbursement policies that shorten hospital stays and reduce overall healthcare costs.

4. What challenges restrain faster expansion?

High capital outlay for shock-wave and holmium lasers, limited access in low-income regions, stringent sterilization protocols, and procedure-related complication risks collectively temper uptake and elongate hospital decision cycles.

5. Which regions lead the market?

North America commands over 42% share thanks to high stone prevalence, robust reimbursement, and early tech adoption; Europe follows, while Asia-Pacific is poised for the fastest growth on rising healthcare spend and medical tourism.

6. Who are the top companies?

Boston Scientific, Olympus, Richard Wolf, Becton Dickinson, Coloplast, and DirexGroup dominate through broad lithotripsy and ureteroscopy portfolios, continuous R&D, and strategic distributor partnerships that secure hospital GPO contracts globally.

7. What future opportunities exist?

Portable dusting lasers, single-use digital scopes, AI-guided stone localization, tele-urology platforms, and expanding ambulatory surgery centers present untapped avenues for product differentiation and penetration in emerging markets.

8. How is technology reshaping procedures?

Advanced thulium fiber lasers reduce retropulsion, disposable flexible ureteroscopes cut cross-contamination, and augmented-reality imaging enhances stone targeting—together boosting stone-free rates and shortening learning curves for urologists.

9. What does the regulatory landscape look like?

FDA 510(k) clearances emphasize clinical equivalence, while the EU MDR demands rigorous post-market surveillance and unique device identification; compliance costs are rising but create barriers that protect premium players in the Urolithiasis Medical Device market.

Contact for Full Report

Loading report content...

Urolithiasis Medical Device - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Market Snapshot

Urolithiasis Medical Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Urolithiasis Medical Device Segmentation

Urolithiasis Medical Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Urolithiasis Medical Device market size?

2. What growth is forecast for the next five years?

3. What are the primary market drivers?

4. What challenges restrain faster expansion?

5. Which regions lead the market?

6. Who are the top companies?

7. What future opportunities exist?

8. How is technology reshaping procedures?

9. What does the regulatory landscape look like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Urolithiasis Medical Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Urolithiasis Medical Device Segmentation

Urolithiasis Medical Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Urolithiasis Medical Device market size?

2. What growth is forecast for the next five years?

3. What are the primary market drivers?

4. What challenges restrain faster expansion?

5. Which regions lead the market?

6. Who are the top companies?

7. What future opportunities exist?

8. How is technology reshaping procedures?

9. What does the regulatory landscape look like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation